Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
Chronic kidney disease (CKD) is characterized by persistent inflammation and progressive fibrosis, ultimately leading to end-stage renal disease. Although many studies have investigated the factors involved in the progressive deterioration of renal function, current therapeutic strategies only delay...
Main Authors: | Sandra Rayego-Mateos, Raul Rodrigues-Diez, Jose Luis Morgado-Pascual, Floris Valentijn, Jose M. Valdivielso, Roel Goldschmeding, Marta Ruiz-Ortega |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/8739473 |
Similar Items
-
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells
by: Jose L. Morgado-Pascual, et al.
Published: (2015-01-01) -
Inflammatory and Fibrotic Mediators in Renal Diseases
by: Sandra Rayego-Mateos, et al.
Published: (2019-01-01) -
Bisphenol A Modulates Autophagy and Exacerbates Chronic Kidney Damage in Mice
by: Alberto Ruiz Priego, et al.
Published: (2021-07-01) -
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
by: Jose Luis Morgado-Pascual, et al.
Published: (2018-01-01) -
Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
by: Sebastian N. Knoppert, et al.
Published: (2019-07-01)